PanTheryx Welcomes Wilderness Medicine Practitioner Stuart Harris to its Board of Directors

 Dr. Harris Joins PanTheryx’s Board to Help Advance Digestive and Immune Health Research and Consumer Awareness

As reported on Business Wire September 28th, 2021

 PHOENIX, Ariz. – September 28, 2021PanTheryx, an integrative digestive and immune health company, today announced the addition of N. Stuart Harris, M.D. to its Board of Directors. Dr. Harris is chief of the Massachusetts General Hospital (MGH) Division of Wilderness Medicine, which is the practice of resource limited medicine under austere conditions. As a PanTheryx board member, Dr. Harris will collaborate with the company’s leadership team and its scientific advisory board to advance research focused on probiotics and cow colostrum for digestive and immune health.

“We are pleased to welcome Dr. Harris to PanTheryx’s board of directors as he brings a unique perspective to preventative health and wellness,” said David Abramson, executive chairman of the board of directors, PanTheryx. “Dr. Harris’ clinical and field research as well has his extensive experience working with diverse populations will give PanTheryx new insights as we create high-quality health and wellness products that target digestive and immune health.”

Dr. Harris brings more than twenty years of experience in emergency medicine, clinical research, and the interplay between the environment and human health. Dr. Harris is a full-time attending physician in the MGH Emergency Department, an Associate Professor of Emergency Medicine at Harvard Medical School, and an affiliated faculty member at the Arctic Initiative at the Belfer Center, Harvard Kennedy School of Government.

Dr. Harris graduated from the Harvard Affiliated Emergency Medicine Residency in 2003. His research focuses on investigating the pathogenesis and treatment of high-altitude illness and on the relationship between climate change and human health. His research teams are active on/in the Himalayas, Mt. Kilimanjaro, the Andes, Alaska, and far Eastern Siberia and have been funded by the National Institutes of Health, the U.S. DOD, MGH, and HMS.

“As a wilderness medicine expert and emergency physician, I’ve experienced the power of proper nutrition to keep all of the body’s systems operating at optimal capacity by supporting the microbiome,” commented Dr. Stuart Harris. “I’m excited to be member of PanTheryx’s board of directors to help impact clinical nutrition research and underscore how the digestive system is critical to health and wellness.”   To learn more about PanTheryx, please visit www.pantheryx.com.

About PanTheryx

PanTheryx™ is a nutrition and biotechnology company committed to the global commercialization of health and wellness solutions for the human and animal health markets. From leading cutting-edge research, to supplying best-in-class ingredients, to commercializing category-leading consumer brands, PanTheryx is dedicated to delivering revolutionary approaches for digestive, immune, and microbiome health. As the world’s largest producer of colostrum, PanTheryx provides its proprietary ColostrumOne™ and La Belle® Colostrum ingredients to its partners serving the global human and animal health markets. In addition to the products it develops with its partners, the PanTheryx portfolio of consumer brands include TruBiotics®, Goodgut®, Life’s First Naturals™ and DiaResQ®. To learn more about PanTheryx, its consumer brands, and colostrum ingredients, please visit www.pantheryx.com.